## **Core Concept**
Dense deposit disease (DDD) is a rare and distinct form of glomerulonephritis characterized by the deposition of dense material within the glomerular basement membrane. It falls under the category of membranoproliferative glomerulonephritis (MPGN), specifically type II. This condition is often associated with the alternative pathway of complement activation.

## **Why the Correct Answer is Right**
The correct answer, **C. Dense Deposit Disease**, is characterized by the accumulation of dense deposits within the glomerular basement membrane, which can be visualized under electron microscopy. This condition is also known as membranoproliferative glomerulonephritis type II (MPGN II) and is often linked to uncontrolled activation of the alternative complement pathway, sometimes due to mutations in the CFH gene or the presence of C3 nephritic factor.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not correspond to Dense Deposit Disease. Without specific details on the other options, we can infer based on the context that they do not accurately describe DDD.
- **Option B:** Similarly, this option does not match the description of Dense Deposit Disease.
- **Option D:** This option also does not correspond to Dense Deposit Disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Dense Deposit Disease is its association with **complement dysregulation**, particularly involving the alternative pathway. Patients with DDD are at increased risk of developing **C3 glomerulopathy**, which includes both DDD and C3 glomerulonephritis. This association is crucial for understanding the pathophysiology and potential therapeutic targets.

## **Correct Answer:** C. Dense Deposit Disease